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Glomerulosclerosis is one of the complications of diabetes
that occurs after many years of uncontrolled hyperglycemia.
Mesangial cells (MCs) exposed to high glucose (HG) for short
periods have shown that transforming growth factor-b
(TGF-b) and activated diacylglycerol-dependent protein
kinase C (PKC) mediate increased collagen formation. Our
study examined collagen formation by MCs exposed to HG
for 8 weeks. Exposure to HG in overnight culture resulted in
the activation of all PKC isoforms. In contrast, 8-week
exposure to HG resulted in the persistent activation of PKC-d,
did not change PKC-a or -b activity, and decreased PKC-e
activity while increasing collagen I and IV gene and protein
expression. Collagen IV accumulation was reversed by
specific PKC-d inhibition. Collagen IV gene expression was
completely normalized by TGF-b neutralization; however, this
was associated with plasminogen activator inhibitor-1 (PAI-1)
overexpression and a modest reduction in collagen protein.
Our studies suggest that prolonged exposure to HG results in
PKC-d-driven collagen accumulation by MCs mediated by
PAI-1 but independent of TGF-b.
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Our group and others have emphasized the altered metabolic
activity of mesangial cells (MCs) in the pathobiology of
diabetic glomerulosclerosis. The initial, most characteristic
glomerular lesion of diabetes is mesangial extracellular
matrix (ECM) deposition, which precedes interstitial dis-
ease.1–4 This lesion may progress despite the absence of
microalbuminuria in humans and experimental animals.5,6
Thus, although podocyte injury and progressive interstitial
alterations may be significant,7–9 the heightened ECM
formation/deposition has generally been considered central
to the pathogenesis of diabetic nephropathy.
MCs and other cells in tissue culture, exposed for 60 min
to 4 weeks to high glucose (HG) concentrations, synthesize,
independent of associated osmolarity changes, increased
ECM that accumulates in the conditioned medium and cell
layer.10–14
Consequently, hyperglycemia is considered a critical factor
for diabetic mesangial expansion with the attendant aug-
mentation of ECM. Intuitively, because glomerulosclerosis
occurs only after long-standing diabetes, MC chronically
exposed to HG is a more relevant in vitro correlate to the
in vivo circumstance. However, a single previous study of
MCs incubated in HG for 8 weeks documented a gradual
decrease in collagen formation, and it was concluded that HG
does not persistently stimulate MC collagen synthesis.15 This
postulate contradicts observations of progressive MC-in-
duced glomerular collagen accumulation in vivo.
Numerous studies have demonstrated increased protein
kinase C (PKC) activity in MCs exposed to HG for short
periods of time (6 h to 8 days) and implicated the activation
of PKC isoforms as a major contributor to signaling events
that led to increased ECM synthesis.12,16–21 Isolated glomeruli
and MCs in culture express specific PKC isoforms including
those represented in diacylglycerol (DAG)-sensitive conven-
tional (PKC-a, -bI, -bII) and novel groups (PKC-d, -e), and
those in the DAG-insensitive atypical group (PKC-z).22–24
The differential overexpression and discrete subcellular
localization of PKC has been found in isolated glomeruli of
streptozotocin-diabetic rats studied within 2–4 weeks after
disease initiation.22,25–28 HG-induced PKC activation is
intimately linked to multiple alterations that convene to
enhance ECM formation and accumulation, including
NADPH oxidase upregulation and reactive oxygen species
formation,29,30 activation of extracellular signal-regulated
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protein kinase (ERK1/2) signaling,31 stimulation of angio-
tensin II production,18 enhancement of TGF-b expres-
sion,32,33 and suppression of ECM catabolism by activation
of plasminogen activator inhibitor-1 (PAI-1) transcription.34
PKC activity has been assessed by two different ap-
proaches, previously. In the first approach, overall or
isoform-specific immunoprecipitate PKC activity has been
determined, according to PKC-specific substrate phosphory-
lating activity.27,28,35–38 In the second approach, specific PKC
isoform activity has been evaluated according to the degree of
kinase membrane association.36,39,40 However, this second
approach may be problematic. It has been shown that newly
synthesized, catalytically inactive, unphosphorylated PKC is
localized exclusively to the membrane fraction.41 Phosphor-
ylation of this newly synthesized PKC is initiated by
3-phosphoinositide-dependent kinase-1 (PDK)-1, followed
by autophosphorylation and release of the mature, catalyti-
cally competent enzyme into the cytosol and maintained in
an inactive state by binding to the autoinhibitory pseudo-
substrate.42 Enzymatic activation of pPKC occurs by DAG-
mediated membrane translocation and phosphatidylserine
generation, Ca2þ -dependent binding of anionic phospholi-
pids, and release of the pseudosubstrate.43 Therefore, not
all pPKC is membrane-bound and active and, conversely, not
all membrane-bound PKC is phosphorylated or active and all
membrane-associated pPKC is believed to be active.42,43
It is not unequivocally determined whether altered ECM
accretion is still present in MCs after long-term HG exposure
or what mechanisms maintain enhanced ECM accumulation
under such conditions. Therefore, we quantified MC collagen
metabolism after long-term HG exposure and the role of
specific PKC isoforms and TGF-b in regulating this activity.
PKC activity has been assessed according to the membrane-
associated content of DAG-sensitive pPKC. The results
indicate that MCs exposed to HG for long periods continue
to accumulate excessive amounts of collagen and that the
mechanisms maintaining this chronically enhanced collagen
accretion differ from those during a short HG exposure.
RESULTS
Effects of different periods of HG exposure on MC collagen
formation
As described by others, collagen I was the predominant form
synthesized by MCs in tissue culture.44,45 In normal glucose
(NG) concentration, collagen I formation was 40-fold that of
collagen IV. Notably, the amount of collagen formed by
control, NG-incubated cells was not significantly different
between 2 and 8 weeks in tissue culture (Figure 1).
Short-term HG induced significant increases in collagen
accumulation in the conditioned media that were more
greatly accentuated for collagen IV than collagen I. The
collagen IV increase was already significant by 48 h (NG,
0.85270.080 ng/ng DNA; HG, 0.95970.096 ng/ng DNA,
n¼ 11, P¼ 0.012). This HG-induced change was augmented
at 2 weeks with respective increases for collagen IV and I of
13- and 2-fold over controls (Figure 1). After long-term HG
exposure, the magnitude of the HG-induced stimulation of
collagen accumulation was less than in short-term HG-
exposed cells, yet was still significantly increased (Figure 1).
Under these conditions, collagen IV and I gene expressions
were increased by 24 and 35%, respectively (Figure 2).
Effects of different periods of HG exposure on MC PKC
isoform activity
The fraction of pPKC that associated with the membrane
preparation was considered an index of PKC activation.
Accordingly, a wide variation in total PKC phosphorylation
vs activity was observed in different isoforms in NG (5 mM)
and HG conditions. For example, in NG-incubated MCs,
approximately 25% of total pPKC-a was membrane-asso-
ciated whereas 70% of detectable pPKC-d was contained in
the membrane fraction (Figures 3 and 4).
Long-term MC HG exposure did not alter total PKC,
but HG statistically decreased the total content of pPKC-a,
-bII, -d, and -e by 13.0–19.5% (Figure 3). This reduced
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Figure 1 | Collagen media accumulation in MCs after a 2- or
8-week incubation in HG concentration. Primary rat MCs were
cultured in a 5 or 25 mM glucose medium containing 15% fetal bovine
serum for 2 weeks (short-term) or 8 weeks (long-term). Cultures were
studied at 80–90% confluence after 48 h of serum deprivation (1%).
Conditioned media were analyzed for collagen I and IV content by
ELISA and results adjusted per DNA content in the cell layer. Results
are mean7s.e.m., n¼ 11–12 per group (*Po0.001).
Kidney International (2007) 72, 1216–1225 1217
MHA Baccora et al.: Mesangial cell PKC and collagen in high glucose o r i g i n a l a r t i c l e
phosphorylation occurred concurrent with unchanged mem-
brane-associated and membrane/cytosolic distribution of
pPKC-a and pPKC-bII isoforms and a decreased mem-
brane-associated pPKC-e (Figures 3–5). Only pPKC-d
demonstrated significant increases of 49 and 36% in the
membrane-associated and membrane/cytoplasm fractions,
respectively (Figures 3–5). Thus, by membrane pPKC
content, long-term HG either did not alter or reduce isoform
activities, except for PKC-d, which was activated over NG
controls.
The effects of rottlerin, a specific PKC-d inhibitor at low
concentrations, were studied in HG-exposed MCs. Treatment
with 0.5 mM rottlerin induced a significant decrease in
collagen IV accumulation to levels equivalent to NG controls.
Increases in rottlerin concentration were associated with
additional decrements in collagen IV accumulation (Figure 6).
In addition, 0.5 mM rottlerin had no effect on collagen IV
accumulation in NG controls (Figure 6).
PKC inactivation of most isoforms by long-term HG
exposure contradicts prior findings recorded in MCs after
short-term HG incubation. The possibility that these
opposing responses resulted from differential methodological
approaches was explored. To reproduce findings by others,
studies were repeated after 24 h of HG incubation, using the
same membrane pPKC parameter as an indicator of
activation. This period of HG was selected because this
interval has been the most frequently used in former
studies.17,20,21,23 Short-term HG incubation significantly
increased the amount of membrane-associated pPKC-a,
pPKC-bII, pPKC-d, and PKC-e by 23.3, 21.1, 30.4, and
37.9%, respectively, as well as the membrane/cytoplasmic
distributions of pPKC-bII and pPKC-d (Figures 4, 5, and 7).
Role of TGF-b in the enhanced collagen formation after
long-term HG exposure
Cultured MCs house a completely functional TGF-b/Smad
signaling pathway, which exerts substantial regulatory control
over collagen synthesis.46–48 Additionally, there is a synergistic
profibrogenic relationship between TGF-b/Smad and PKC
signaling. TGF-b activates PKC-d-dependent enhancement of
collagen gene expression that is not observed with the a- or
bI-isoform.37 The observation that only the d-isoform was
HG-activated implies that TGF-b-enhanced collagen forma-
tion may proceed through this isoform. Therefore, the role of
TGF-b was studied by quantifying MC collagen expression
following TGF-b neutralization in cells maintained under
long-term HG conditions.
Long-term HG MC exposure elevated TGF-b formation
twofold over NG control levels (Figure 8), and antibody-
mediated TGF-b neutralization produced significant
decreases of TGF-b1 concentration in NG and HG (Figure 8).
In HG, the cytokine increase was abrogated completely to NG
control values by antibody neutralization and also inducing a
complete reversal of HG-induced collagen IV mRNA over-
expression (Figure 8). However, normalizing TGF-b levels
resulted only in modest (17%) amelioration of the exagger-
ated accumulation of collagen, with collagen IV quantities
still fourfold greater than NG controls (Figure 8). This
observation suggests a reduction of protein catabolism,
independent of TGF-b overexpression. Furthermore, TGF-
b-mediated PKC-d activation in MCs unlikely represents a
principal pathway of HG-associated collagen accumulation.
Lastly, under NG conditions, TGF-b neutralization to
subnormal levels did not alter collagen IV mRNA or protein
expression (Figure 8).
PAI-1 activity is an important determinant of MC ECM
degradation and turnover in vitro.49 HG and glycated
proteins induce MC PAI-1 transcriptional activation via
PKC-d and TGF-b/Smad-dependent mechanisms.50,51 Ac-
cordingly, MC PAI-1 expression was studied in HG and
during TGF-b inhibition. PAI-1 mRNA and protein expres-
sions were increased 1.5- and 3-fold, respectively, by HG
compared to NG controls (Figure 9). TGF-b neutralization
increased gene expression, but did not alter PAI-1 protein
formation in NG. However, in HG, TGF-b inhibition caused
an unanticipated significant increase of MC PAI-1 mRNA
and protein overexpression (Figure 9). Taken collectively, the
results suggest that, after TGF-b neutralization and norma-
lization of collagen IV gene overexpression, the continual
collagen IV accrual stems from a PAI-1-dependent decrease in
protein degradation (Figures 8 and 9).
DISCUSSION
MCs in tissue culture characteristically demonstrate a rapid
turnover of collagen. Work by us and others has shown brisk
synthesis and breakdown of newly formed collagen, achieving
steady-state conditioned medium concentrations within 24 h,
with only 3% of the total synthesized collagen deposited in
the cell layer.47,52 Therefore, data presented here on collagen
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Figure 2 | Collagen gene expression in MCs after an 8-week
incubation in HG concentration. Primary rat MCs were cultured as
in Figure 1. Total RNA was extracted from the cell layer and collagen I
and IV mRNA expression quantified by multiplex, real-time RT-PCR.
Results were adjusted for the expression of b-actin. Results are
mean7s.e.m., n¼ 10 per group (*Po0.001, wP¼ 0.007).
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medium accumulation reflect the major part of collagen
turnover activity under steady-state conditions.
Experimentally induced mesangial expansion in the
insulin-deficient rat involves excessive ECM deposition,
including collagen IV. This is evident at 8 weeks and
definitively established by 9–12 months.53–55 Accordingly,
the 8-week exposure of rat MCs in tissue culture utilized to
test our hypothesis mimics the in vivo model.
There are no studies available of MCs in tissue culture
comparable to the present investigation. A single previous
investigation of long-term effects of HG on MCs with a
different experimental approach did not address PKC activity
and revealed a paradoxical decrease in collagen synthesis,
with unchanged gene expressions of collagens I and IV.15
Regarding short-term HG incubation, the present study
confirms the previously acknowledged increases in collagens I
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Figure 3 | PKC isoform activity in MCs after an 8-week incubation in HG concentration. Primary rat MCs were cultured as in Figure 1.
Cell layer hydrolysates were analyzed for total PKC isoform or phosphorylated isoform by immunoblotting. Phosphorylated isoforms were
also quantified in crude membrane preparations and in the corresponding cytosolic fractions to determine their membrane-associated amount
and the membrane/cytosolic ratio. Data were normalized by the amount of protein loaded and expressed relative to control values (total
amount, membrane-associated) or as an unadjusted ratio (membrane/cytosolic). Results are mean7s.e.m., n¼ 6 individual samples per group,
analyzed in duplicate.
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and IV expression.10,56 In addition, these changes endure with
prolonged HG exposure, signifying their importance in the
pathogenesis of glomerular mesangial expansion. Sub-
sequently, we sought to identify factors responsible for
maintaining protracted collagen accrual, and potential
pathobiological mechanisms of PKC and TGF-b activation
were studied.
Short-term exposure of MCs to HG activated DAG-
sensitive PKC isoforms, and this result was most evident for
pPKC-bII and -d, the latter of which demonstrated increased
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Figure 4 | Membrane-associated content of phosphorylated PKC
isoforms in MCs after short- and long-term incubation in HG
concentration. Examples of immunoblots of proteins contained in
detergent extracts of MC membrane preparations are presented.
Cells were exposed to 25 mM glucose medium for 24 h (short-term) or
8 weeks (long-term).
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Figure 5 | Membrane/cytoplasm distribution of phosphorylated
PKC isoforms in MCs after short- and long-term incubation in HG
concentration. Presented are examples of immunoblots of proteins
contained in the membrane (M) and cytosolic (C) fractions
corresponding to the same sample of MC protein. Cells were
exposed to 25 mM glucose medium for 24 h (short-term) or 8 weeks
(long-term).
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Figure 7 | PKC isoform activity in MCs after a 24-h incubation in
HG concentration. MCs were cultured and cell lysates analyzed for
PKC isoform-specific activation as in Figure 3. Results are
mean7s.e.m., n¼ 10 individual samples per group, analyzed in
duplicate.
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membrane translocation. These data are in agreement with
previous studies.16,34,36 In particular, they are consistent with
observed specific HG-induced increases in PKC-d activity,
detectable at 72 h as documented in isoform-specific
immunoprecipitates by a kinase assay.57
PKC signaling activity is distinctly altered by chronic HG
exposure that overall deactivates the DAG-sensitive PKC
isoforms. Compared to NG-incubated controls, the total
content of all pPKC isoforms was decreased by HG, and PKC-a
and -bII revealed no evidence of increased activity. Also, the
amount of membrane-associated pPKC-e was reduced,
although PKC-d clearly remained activated. Consequently,
this activation is critical for persistent collagen accumulation
as delineated by the rottlerin dose–response relationship
between collagen accumulation and concentration of PKC-d
inhibitor. This effect was specifically evident in HG-exposed
cells at only one-tenth the concentrations used previously for
PKC-d inhibition in NG-incubated MCs.37,57 However, there
has been controversy regarding the specificity of rottlerin. At
X30 mM, it inhibits other PKC isoforms and is known to
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inhibit calmodulin-dependent kinase III (IC50 5.3 mM). Also,
rottlerin may uncouple oxidative phosphorylation
(3–10 mM).58–61 Nevertheless, any of these effects are unlikely
at the very low concentrations applied in our experiments
(0.5–2.0 mM). Furthermore, recent studies have reinforced the
effectiveness and specificity of rottlerin as a PKC-d inhibitor
in mesangial and neuronal cells.38,57
The level of PKC activity demonstrated in MCs exposed to
HG for 8 weeks in this study differs from results in isolated
glomeruli of long-term diabetic rats. Studies in 24-week
diabetic animals have shown an increase in glomerular total
PKC phosphorylating activity.28,62 In addition, total content
of pPKC-a and pPKC-bI and total (phosphorylated and non-
phosphorylated) membrane-associated amounts of these
isoforms are also increased in 12-week diabetic rats.32 Other
studies in glomeruli from 4-week diabetic rats have
demonstrated increased membrane association of total
PKC-a, -d, and -e isoforms, with decreased PKC-b.22 One
explanation for the discrepant results between glomeruli and
MCs in this study is the differential assessment of PKC
activation, that is, glomerular studies have not included the
specific membrane association of phosphorylated isoforms.
A more plausible reason is the heterogeneity of glomeruli,
of which MCs represent a fraction of the total cell population.
The PKC-b inhibitor LY333531 in 4-month diabetic
animals reduces albuminuria and prevents mesangial expan-
sion.25,62 However, these data do not prove the pathogenetic
importance of PKC-b activation. Inhibition of normal PKC-b
activity to levels below those of basal conditions may be
associated with suppression of mesangial collagen formation,
irrespective of glycemia. That is, the inhibitor may be
effective even when its therapeutic target is not relevant.
Activation of the TGF-b/Smad signaling pathway is
considered an important component of HG-mediated
stimulation of MC collagen synthesis, by virtue of short-
term studies.63,64 In addition, there is a close relationship
between HG-induced alterations of PKC and TGF-b signaling
pathways that has been defined in short-term investiga-
tions.33,57,65 Relevant to this study are observations in MCs
and other cells of TGF-b-induced activation of PKC-d and
PKC-d-dependent TGF-b signaling.37,57,66 In this study,
complete abolition of TGF-b overexpression completely
normalized HG-augmented collagen IV mRNA expression,
whereas collagen IV protein accumulation was only moder-
ately reduced. Under these circumstances, the vast part of
collagen accumulation was attributed to TGF-b-independent
PAI-1 upregulation with diminution of collagen breakdown
that was accentuated by TGF-b neutralization. These results
are in contrast to the findings of others though, where short-
term treatment of MCs with TGF-b or oxidized low-density
lipoprotein to induce TGF-b activation stimulated PAI-1
transcription.67,68
Therefore, the apparent main cause for collagen accumu-
lation after long-term HG exposure is diminished collagen
breakdown that is contingent on PKC-d activation. Thus,
TGF-b overactivity increases collagen synthesis but is only
responsible for a minor fraction of the collagen accumulated.
The results obtained in this study are in agreement with the
demonstration of PAI-1 upregulation by HG in MCs in vitro
and by diabetes in vivo,69–71 and concordant with the
observation that PAI-1 activity is a major pathogenetic
component in the development of experimental diabetic
nephropathy.72 Notably, these observations are also in
concert with the demonstration that PAI-1 gene expression
is stimulated by HG in MCs through PKC-d.50
The reasons for the differential behavior of MCs after
short- and long-term HG exposure may be ascribed to
differences in the stimuli (glucose concentration vs glycox-
idative stress) and/or clonal selection of MC populations with
specific phenotype.73 In either case, we assume that the same
occurs in vivo.
In conclusion, long-term HG exposure induces MC ECM
accumulation via a PKC-d-driven, PAI-1-mediated, and
largely TGF-b-independent mechanism. Because the con-
tribution of individual pathogenetic mechanisms maintain-
ing this accumulation changes with time, the targets of
therapeutic intervention should be primarily defined during
chronic HG conditions.
MATERIALS AND METHODS
Tissue culture
Primary MCs were obtained from outgrowths of isolated glomeruli
from Munich–Wistar rats.74 Cells were grown in 75 cm2 flasks
(Corning Inc., Corning, NY, USA) or six-well plates (Becton
Dickinson, Lincoln Park, NJ, USA) in RPMI medium 1640 (Gibco
BRL, Grand Island, NY, USA), pH 7.4, containing, 2 mM L-
glutamine, 23.8 mM NaHCO3, 15% fetal bovine serum (Gibco
BRL, Grand Island, NY, USA), 5 U/ml penicillin G, and 5 U/ml
streptomycin. Cells were used at passage 3 and continuously grown
in NG (5 mM) or in HG (25 mM) for 24, 48 h, 2 weeks (short-term),
or 8 weeks (long-term). All studies were carried out in 48-h serum-
deprived (1% fetal bovine serum) cells at 80–100% confluency. As
previously shown by us, overall collagen accumulation rapidly
decreases as cultures became more confluent.75 This effect tends to
blunt differences between groups, as results are expressed per total
DNA. Neutralization of TGF-b activity was accomplished by adding
3 mg/ml of mouse monoclonal-1835 TGF-b antibody (R&D System
Inc., Minneapolis, MN, USA) or a nonspecific mouse IgG to the
incubation medium every 24 h during the last 48 h of the
experiment. Rottlerin was purchased from Calbiochems (EMD
Biosciences Inc., La Jolla, CA, USA).
Harvesting and cell fractionation
Cell layers were obtained in lysis buffer containing 20 mM Tris-HCl,
150 mM NaCl, 2 mM EDTA, 5 mM EGTA, 1 mM dithiothreitol, 1 mM
phenylmethylsulfonyl fluoride, 100mM leupeptin, 30 mM pepstatin,
10 mM benzamidine, 50 mM sodium fluoride, 20 mM E-64, 50 mg/ml
aprotinin, 1.2 mM sodium vanadate, 5 mM sodium pyrophosphate,
and 1% Triton X-100. Samples were sonicated on ice using a
CPX130PB sonicator (Cole Parmer Instruments, Vernon Hills, IL,
USA) at 20% amplitude for 5 s and then centrifuged in a Beckman
22R centrifuge (Beckman Instruments, Palo Alto, CA, USA) at
2000 g and 41C for 5 min to remove cell debris.
For membrane isolations, Triton X-100 was omitted from the
lysis buffer. Crude membrane preparations were obtained as
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described previously.76 In these experiments, after the initial
centrifugation, supernatants were centrifuged at 100 000 g at 41C
for 60 min in a Coulter LE-80 Series with Rotor SW 50.1 (Beckman).
The resulting supernatants constituted cytosolic fractions and pellets
were resuspended in 400 ml of the same lysis buffer containing 1%
Triton X-100 by sonicating at 10% amplitude for 1 s and incubating
on ice for 30 min with frequent vortexing. Resuspended pellets were
re-centrifuged and supernatants collected as the membrane-
associated fraction. Lack of cross-contamination between cytosolic
and crude membrane preparations was documented by immuno-
blotting according to the restricted presence of Naþ -Kþ -ATPase
and sarcoendoplasmic reticulum Ca2þ -ATPase in the particulate
fraction and of glyceraldehyde-3-phosphate dehydrogenase in the
cytosolic supernatant.77
Immunoblotting
Protein measurement was assayed by a modified Lowry method.78,79
Equal amounts of protein were loaded and separated on 4–15%
SDS-polyacrylamide gels (Jule Biotechnology Inc., Milford,
CT, USA), blotted onto polyvinylidene difluoride membranes
(Millipore, Bedford, MA, USA), and then blocked in Tris-buffered
saline (Mediatech Inc., Herndon, VA, USA) containing 0.05% Tween
20 (TTBS) and 5% nonfat milk powder. pPKC/PKC isoforms were
identified by reaction with the following isoform-specific antibodies:
polyclonal rabbit anti-pPKC-a (Upstate Co., Lake Placid, NY, USA),
polyclonal rabbit anti-pPKC-e (Upstate Co.), polyclonal rabbit
anti-pPKC-a/bII (Cell Signaling Technologys, Danvers, MA, USA),
polyclonal goat anti-pPKC-d (Santa Cruz Biotechnology, Santa
Cruz, CA, USA), monoclonal mouse anti-PKC-a, -b, -d, and -e (BD
Biosciences, Pharmingen, San Diego, CA, USA). After being washed,
membranes were incubated with species-specific secondary horse-
radish peroxidase-conjugated antibodies: donkey anti-goat (Santa
Cruz Biotechnology), donkey anti-rabbit and sheep anti-mouse
antibodies (Amersham Bioscience, GE Healthcare, Buckinhamshire,
UK). Immunoreactive bands were visualized with ECLTM detection
reagent and exposure to HyperfilmTM (Amersham Bioscience).
Uniformity of loading and equal membrane transfer was determined
in parallel membranes stained with Coomassie blue. Films and
Commassie blue-stained membranes were scanned and bands
analyzed using the National Institute of Health ImageJ v1.33U gel
plotting software to obtain densitometry measurements. The sum of
all protein bands contained in each sample lane in Coomassie blue-
stained membranes was considered equivalent to the amount of
loaded/membrane-transferred protein.
After first determining the variation between NG controls, the
relative abundances of pPKC/PKC isoforms between groups were
ascertained by comparison to values resulting from a pooled sample
of NG control protein that was included in each electrophoretic
separation. The ratio membrane/cytosolic fraction of individual
pPKC isoforms was directly calculated from the results of membrane
and cytosolic samples separated in the same gel. Final results
were adjusted for differences in protein loading/transfer when
indicated.
Enzyme-linked immunosorbent assay
The concentration of collagens I and IV in 48-h conditioned media
was determined in 96-well plates (Microfluors 2 black flat-bottom
microtiter plates; Thermo Electron Co., Milford, MA, USA) by a
high-sensitivity direct enzyme-linked immunosorbent assay (ELI-
SA). Samples were diluted in coating buffer (51 mM NaHCO3,
115 mM Na2CO3, pH 9.4) and incubated overnight. After being
washed, plates were treated with 0.5% bovine serum albumin and
0.1% Tween 20 dissolved in blocking buffer (137 mM NaCl, 8.8 mM
Na2HPO4  2H2O, 1.5 mM KH2PO4, and 2.7 mM KCl, pH 7.4) for 1 h
and incubated overnight in the corresponding primary antibody
(rabbit anti-rat collagen I, Chemicon Int., Temecula, CA, USA;
affinity-purified rabbit anti-rat collagen IV, Rockland Inc., Gilberts-
ville, PA, USA). After being extensively washed, plates were treated
with a horseradish peroxidase-conjugated goat anti-rabbit IgG
(Invitrogen, Carlsbad, CA, USA) for 3 h. Finally, samples were
incubated for 20 min with 0.05 mM Texas Red reagent (Invitrogen)
and fluorescence intensity was determined in a Fluorskan Ascent FL
(Thermo Electron Co.) at 530excitation/590emission. Results were
analyzed using a curve-fitting software (Interactive Microware, State
College, PA, USA). Purified rat collagen type I (Upstate Biotechnol-
ogy, Valerica, MA, USA) and type IV (Santa Cruz Biotechnology)
were used as standards. Total TGF-b1 and PAI-1 proteins in the
conditioned media were measured using ELISA Quantikines (R&D
Systems) and PAI-1 (Aniara, Mason, OH, USA) kits following the
manufacturers’ instructions. The ELISA assay for TGF-b reacts
solely with free TGF-b1 and does not recognize the antibody-
neutralized growth factor.
DNA content
Cell layers were obtained in a 10 mM sodium phosphate lysis buffer,
pH 7.5, containing 150 mM NaCl, 2 mM EDTA, 1% Igepal, and 1%
sodium deoxycholate. Samples were homogenized and centrifuged
at 26 000 g for 20 min at 41C. The resulting supernatants were used
for DNA measurement by a fluorescence method using the
PicoGreenTM dsDNA Kit (Molecular Probes Inc., Eugene, OR,
USA) according to the manufacturer’s directions.
Quantitative, real-time gene expression
Total RNA was extracted using the RNeasy mini Kit (Qiagen Inc.,
Valencia, CA, USA) after DNase treatment. The approach for the
measurement of gene expression was a one-step reverse transcrip-
tion (RT)-PCR with specific FRET probes using a multiplex mode
(gene of interest and housekeeping gene expression measured
simultaneously in the same reaction) in a LightCyclers (Roche
Molecular Biochemicals, Manheim, Germany). Reactions were
carried out in triplicate using SuperscriptTM III one-step QRT-PCR
Platinum probe (Invitrogen) kit. As reference gene we used b-actin,
because our recent studies have demonstrated this gene to be one of
the most stable genes in MCs cultured in HG conditions.80
Statistical analysis
Protein medium accumulation was factored by the total DNA
contained in the corresponding tissue culture well. Statistical
analyses were carried out using the StatViews 5.0.1 software
(Abacus Concepts Inc., Berkeley, CA, USA). Results were expressed
as mean7s.e.m. Results were analyzed by unpaired t-test with the
level of significance calculated by a two-tailed test. In experiments
containing more than two groups, significance was determined by
analysis of variance and differences between groups determined by
Fisher’s protected least significant difference as post hoc test.
Statistical significance was set at 5% level.
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